Chan Kwon Park
0000-0002-4107-444X
Publication & Citation Trends
Publications
0 total
Comparative analysis of alectinib and brigatinib in real-world treatment of advanced NSCLC with ALK rearrangements OA
Cited by 1
Semantic Scholar
Real‐world study of lazertinib as second‐line or greater treatment in advanced non‐small cell lung cancer OA
Cited by 0
Semantic Scholar
Real‐world outcome of crizotinib for anaplastic lymphoma kinase‐positive lung cancer: Multicenter retrospective analysis in South Korea OA
Cited by 2
Semantic Scholar
Real-World Outcomes of Crizotinib in ROS1-Rearranged Advanced Non-Small-Cell Lung Cancer OA
Cited by 10
Semantic Scholar
Optimal timing for local ablative treatment of bone oligometastases in non-small cell lung cancer OA
Cited by 6
Semantic Scholar
Prediction of Postoperative Lung Function in Lung Cancer Patients Using Machine Learning Models OA
Cited by 5
Semantic Scholar
Current literature review on the tumor immune micro-environment, its heterogeneity and future perspectives in treatment of advanced non-small cell lung cancer OA
Cited by 24
Semantic Scholar
The association between clinical parameters and resectability in stage III non-small cell lung cancer, and a combination of N2 lymph node burden and lung immune prognostic index score as a potential biomarker OA
Cited by 1
Semantic Scholar
Research Topics
Lung Cancer Treatments and Mutations
(51)
Lung Cancer Diagnosis and Treatment
(46)
Lung Cancer Research Studies
(21)
Chronic Obstructive Pulmonary Disease (COPD) Research
(17)
Asthma and respiratory diseases
(16)
Affiliations
Hanyang Cyber University
Korea University
Kosin University Gospel Hospital
Moffitt Cancer Center
St. Mary's Hospital